Spiriva [tiotropium bromide] 18g Once Daily in Chinese COPD [chronic obstructive pulmonary disease] Patients of Different Disease Severities
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 19 May 2010 Actual patient number (4918) added as reported by ClinicalTrials.gov.
- 15 Apr 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Mar 2008 New trial record.